福元医药: 北京福元医药股份有限公司关于联苯苄唑溶液获得药品注册证书的公告

Core Viewpoint - The company, Beijing Fuyuan Pharmaceutical Co., Ltd., has received a drug registration certificate for Bifonazole Solution, which will enhance its product line and market competitiveness [1][2]. Drug Registration Information - The drug is named Bifonazole Solution, classified as a non-prescription chemical drug, with a specification of 1% (10ml: 0.1g) [1]. - The drug registration number is H20254937, and it has been approved for domestic production [1]. - The drug is indicated for the treatment of various skin fungal diseases, including tinea pedis, tinea corporis, tinea cruris, candidiasis, and vitiligo [2]. Market Status of Similar Drugs - According to data from Minet, the sales of Bifonazole Solution in China's three major terminal markets reached approximately 375.26 million yuan in 2024, with sales from urban public hospitals and county-level public hospitals amounting to 256.75 million yuan [2].